Commonwealth Equity Services’s TELA Bio TELA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-38,441
Closed -$75K 4429
2025
Q2
$75K Buy
38,441
+10,000
+35% +$13.1K ﹤0.01% 4106
2025
Q1
$35K Hold
28,441
﹤0.01% 4094
2024
Q4
$86K Buy
28,441
+13,555
+91% +$38.1K ﹤0.01% 3930
2024
Q3
$38K Hold
14,886
﹤0.01% 3958
2024
Q2
$70K Hold
14,886
﹤0.01% 3861
2024
Q1
$84K Hold
14,886
﹤0.01% 3829
2023
Q4
$99K Sell
14,886
-385
-3% -$2.23K ﹤0.01% 3673
2023
Q3
$122K Hold
15,271
﹤0.01% 3531
2023
Q2
$155K Buy
+15,271
New +$156K ﹤0.01% 3481

Other funds holding TELA

Commonwealth Equity Services's TELA Position: Q3 2025 in Review

Commonwealth Equity Services sold out of TELA Bio (TELA) in Q3 2025, closing a stake of 38,441 shares — an estimated $75K sold.

Commonwealth Equity Services first reported a position in TELA in Q2 2023 and held it in 9 quarters. The position peaked at $155K in Q2 2023. 40 funds tracked by Wall St. Rank hold TELA as of Q3 2025.

  • Commonwealth Equity Services reported no remaining TELA Bio position as of Q3 2025 after selling out during the quarter.
  • Commonwealth Equity Services sold 38,441 TELA Bio shares in Q3 2025, an estimated $75K.
  • Commonwealth Equity Services first reported a position in TELA Bio in Q2 2023 and held it in 9 quarters.
  • Commonwealth Equity Services's TELA Bio position peaked at $155K in Q2 2023.
  • 40 funds tracked by Wall St. Rank held TELA Bio as of Q3 2025.

Based on Commonwealth Equity Services's 13F filing for Q3 2025, filed 22 Oct 2025.